Austar Lifesciences Ltd.'s total assets for Q4 2024 were ¥2.08B, a decrease of -2.49% from the previous quarter. HK:6118 total liabilities were ¥1.29B for the fiscal quarter, a -4.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.